Generics Maker Suffers Blow In Eye Drug Ruling
The temporary restraining order is the latest development in a patent infringement lawsuit over Acular, an anti-inflammatory eye medicine introduced in 1993 by Allergan Inc.
The ruling, issued Dec. 29, prevents Apotex, Apotex Corp. and Novex Pharma from making or selling a generic version of Acular. It comes as the aging U.S. population increases its...
Already a subscriber? Click here to login